Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Susan Cornell & Jennifer D'Souza. (2014) Pharmacotherapy Considerations in Diabetes and Obesity: Setting Patients up for Success. Postgraduate Medicine 126:2, pages 100-109.
Read now
Read now
Articles from other publishers (7)
Sue D. Pedersen. (2023) How to apply the Canadian Obesity Clinical Practice Guidelines to people with type 2 diabetes. Canadian Diabetes & Endocrinology Today.
Crossref
Crossref
Songsong Liu, Kang Liu, Yuwei Wang, Chou Wu, Yang Xiao, Siqi Liu, Jingsu Yu, Zeqiang Ma, Huanjie Liang, Xiangling Li, Yixing Li & Lei Zhou. (2023) Hesperidin methyl chalcone ameliorates lipid metabolic disorders by activating lipase activity and increasing energy metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1869:2, pages 166620.
Crossref
Crossref
W. Timothy Garvey, Andreas L. Birkenfeld, Dror Dicker, Geltrude Mingrone, Sue D. Pedersen, Altynai Satylganova, Dorthe Skovgaard, Danny Sugimoto, Camilla Jensen & Ofri Mosenzon. (2020) Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care 43:5, pages 1085-1093.
Crossref
Crossref
Megha Abhijit Butala, Subrahmanya Kumar Kukkupuni & Chethala N. Vishnuprasad. (2017) Ayurvedic anti-diabetic formulation Lodhrasavam inhibits alpha-amylase, alpha-glucosidase and suppresses adipogenic activity in vitro. Journal of Ayurveda and Integrative Medicine 8:3, pages 145-151.
Crossref
Crossref
Chun-Ping ChangChien-Huang WuJen-Shin SongMing-Chen ChouYing-Chieh WongYinchiu LinTeng-Kuang YehAmit A. SadaniMing-Hung OuKun-Hung ChenPei-Hsuan ChenPo-Chu KuoChen-Tso TsengKuei-Hua ChangShi-Liang TsengYu-Sheng ChaoMing-Shiu HungKak-Shan Shia. (2013)
Discovery of 1-(2,4-Dichlorophenyl)-
N
-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5-(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1
H
-pyrazole-3-carboxamide as a Novel Peripherally Restricted Cannabinoid-1 Receptor Antagonist with Significant Weight-Loss Efficacy in Diet-Induced Obese Mice
. Journal of Medicinal Chemistry 56:24, pages 9920-9933.
Crossref
Crossref
Chinnadorai Rajeswaran, Rayaan Shaikh & Misbah Mohammad. (2013) Bariatric surgery: a long-term solution to managing diabesity. Practice Nursing 24:12, pages 608-615.
Crossref
Crossref
Andrew J. Krentz & Marcus Hompesch. (2013) Targeting Hyperglycaemia with Anti-Obesity Drugs: Time for a Paradigm Shift?. Drugs 73:15, pages 1649-1651.
Crossref
Crossref